ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Zinder Report Asks VCP To Switch Most Research To Grants, Spread Work Among More Scientists, Change Review Groups

March 22, 1974

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980